However, in the sensitivity analysis based on Bootstrap in Section S4.4 in the Supplementary materials, the association between SLFN11 and Topotecan appears to be the most significant among all gene-drug pairs in terms of heterogeneous effects across cancer types. The gene discussed is SLFN11; the disease is cancer.